SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13E-3
(AMENDMENT NO. 4)
RULE 13E-3 TRANSACTION STATEMENT
UNDER SECTION 13(E) OF
THE SECURITIES EXCHANGE ACT OF 1934
Venoco, Inc.
(Name of the Issuer)
Venoco, Inc.
Denver Parent Corporation
Denver Merger Sub Corporation
Timothy M. Marquez
Bernadette Marquez
Marquez Trust
Timothy and Bernadette Marquez Foundation
(Names of Person(s) Filing Statement)
Common Stock, par value $0.01 per share
(Title of Class of Securities)
92257PAB5
(CUSIP Number of Class of Securities)
Venoco, Inc.
370 17th Street, Suite 3900
Denver, Colorado 80202-1370
(303) 626-8300
|
|
Denver Parent Corporation
Denver Merger Sub Corporation
Timothy M. Marquez
Bernadette Marquez
Marquez Trust
Timothy and Bernadette Marquez Foundation
370 17th Street, Suite 3900
Denver, Colorado 80202-1370
(303) 626-8300
|
(Name, Address, and Telephone Numbers of Person Authorized to Receive Notices
and Communications on Behalf of the Persons Filing Statement)
With copies to
Davis Graham & Stubbs LLP
|
|
Wachtell, Lipton, Rosen & Katz
|
1550 Seventeenth Street, Suite 500
|
|
52 West 52nd Street
|
Denver, Colorado 80202
|
|
New York, New York 10019
|
Attn: John A. Elofson, Esq.
|
|
Attn: Igor Kirman, Esq.
|
(303) 892-9400
|
|
(212) 403-1000
|
This statement is filed in connection with (check the appropriate box):
a.
|
x
|
The filing of solicitation materials or an information statement subject to Regulation 14A, Regulation 14C or Rule 13e-3(c) under the Securities Exchange Act of 1934.
|
|
|
|
b.
|
£
|
The filing of a registration statement under the Securities Act of 1933.
|
|
|
|
c.
|
£
|
A tender offer.
|
|
|
|
d.
|
£
|
None of the above.
|
Check the following box if the soliciting materials or information statement referred to in checking box (a) are preliminary copies:
o
Check the following box if the filing is a final amendment reporting the results of the transaction:
o
Calculation of Filing Fee
Transaction valuation*
|
|
Amount of filing fee
|
|
$395,775,337.50
|
|
$45,355.85
|
|
*
Set forth the amount on which the filing fee is calculated and state how it was determined.
*
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11: the filing fee of $45,355.85 was determined by multiplying .00011460 by the aggregate merger consideration of $395,775,337.50. The aggregate merger consideration was calculated by multiplying the 31,662,027 outstanding shares of common stock to be acquired pursuant to the merger and the merger consideration of $12.50 per share.
x
Check the box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
Amount Previously Paid:
|
$45,355.85
|
Filing Party:
|
Venoco, Inc.
|
Form or Registration No.:
|
Schedule 14A
|
Date Filed:
|
February 13, 2012
|
Introduction
This Amendment No. 4 to Rule 13E-3 Transaction Statement (Transaction Statement) is being filed with the Securities and Exchange Commission (the SEC) pursuant to Section 13(e) of the Securities Exchange Act of 1934, as amended (the Exchange Act), by Venoco, Inc., a Delaware corporation (the Company), Denver Parent Corporation, a Delaware corporation (Parent), Denver Merger Sub Corporation, a Delaware corporation (Merger Sub), Timothy M. Marquez (Mr. Marquez), Bernadette Marquez, the Marquez Trust (the Trust) and the Timothy and Bernadette Marquez Foundation (the Foundation, and collectively, the Filing Persons).
This Transaction Statement relates to the Agreement and Plan of Merger, dated as of January 16, 2012 (as it may be amended from time to time, the Merger Agreement) by and among the Company, Parent, Merger Sub and, solely with respect to the sections specified therein, Mr. Marquez. If the conditions to the closing of the merger are either satisfied or waived, Merger Sub will be merged with and into the Company, the separate corporate existence of Merger Sub will cease and the Company will continue its corporate existence under Delaware law as the surviving corporation in the merger. Upon completion of the merger, each share of the Companys common stock, par value $.01 per share (Common Stock) other than shares owned by the Company, Parent and Merger Sub, and holders who have properly demanded and not withdrawn a demand for appraisal rights, will be converted into the right to receive $12.50 per share in cash, without interest and less any required withholding taxes. Following the completion of the merger, the Common Stock will no longer be publicly traded, and holders of the Common Stock that has been converted will cease to have any ownership interest in the Company.
Concurrently with the filing of this Transaction Statement, the Company is filing with the SEC an amended proxy statement (the Proxy Statement) under Regulation 14A of the Exchange Act, pursuant to which the Companys board of directors is soliciting proxies from stockholders of the Company in connection with the merger. The Proxy Statement is attached hereto as Exhibit (a)(1). A copy of the Merger Agreement is attached to the Proxy Statement as Annex A and is incorporated herein by reference.
Pursuant to General Instruction F to Schedule 13E-3, the information in the Proxy Statement, including all annexes, exhibits and appendices thereto, is expressly incorporated by reference herein in its entirety, and responses to each item herein are qualified in their entirety by the information contained in the Proxy Statement. The cross-references below are being supplied pursuant to General Instruction G to Schedule 13E-3 and show the location in the Proxy Statement of the information required to be included in response to the items of Schedule 13E-3.
All information contained in, or incorporated by reference into, this Transaction Statement concerning each Filing Person was supplied by such Filing Person.
Item 1. Summary Term Sheet
Regulation M-A Item 1001
The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Summary Term Sheet
Questions and Answers about the Special Meeting and the Merger
Item 2. Subject Company Information
Regulation M-A Item 1002
(a)
Name and address
. The Companys name and the address and telephone number of its principal executive offices are as follows:
2
Venoco, Inc.
370 17th Street, Suite 3900
Denver, Colorado 80202-1370
(303) 626-8300
(b)
Securities
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Questions and Answers about the Special Meeting and the Merger
The Special MeetingRecord Date and Quorum
The Special MeetingRequired Vote
Important Information Concerning VenocoSecurity Ownership of Certain Beneficial Owners and Management
(c)
Trading market and price
. The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:
Important Information Concerning VenocoMarket Price of the Companys Common Stock
(d)
Dividends
. The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:
Important Information Concerning VenocoMarket Price of the Companys Common Stock
(e)
Prior public offerings
. The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:
Important Information Concerning VenocoPrior Public Offerings
(f)
Prior stock purchases
. The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:
Important Information Concerning VenocoTransactions in Common Stock
During the past two years, Mr. Marquez has received as part of his compensation from the Company 527,879 shares of restricted Common Stock subject to restrictions on vesting during the quarter ended March 31, 2010, and 262,448 shares of such restricted stock during the quarter ended March 31, 2011.
During the past two years, Parent and Merger Sub have not purchased any Common Stock.
Item 3. Identity and Background of Filing Person
Regulation M-A Item 1003
(a) - (c) The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Summary Term Sheet
Important Information Concerning Venoco
The Parties to the Merger
The Trust and the Foundation are parties to a letter agreement with Parent, dated January 16, 2012, pursuant to which they committed, subject to certain conditions, to contribute all of the shares of Common Stock owned by them at the time of such agreement to Parent in exchange for equity interests in Parent. Mr. Marquez and Mrs. Bernadette Marquez are trustees of the Trust and the Foundation and Mr. David Mokros is a trustee of the Foundation.
The Trust is a personal trust, under that certain Trust Agreement dated February 26, 2002, as amended, and its address is c/o Venoco, 370 17th Street, Suite 3900, Denver, Colorado 80202.
The Foundation is a charitable foundation organized under the laws of Colorado and its address is c/o Venoco, 370 17th Street, Suite 3900, Denver, Colorado 80202.
David Mokros has served as Manager of Timber LLC (the address for which is 370 17th Street, Denver, Colorado 80202) for over five years and has not held any other employment during that time.
Bernadette Marquez performs uncompensated community work for the Company and has not held any other employment during the last five years.
Each of the individuals named above is a U.S. citizen. During the last five years, none of Parent, Merger Sub, the Trust, the Foundation, nor any of the individuals named above has been convicted in a criminal proceeding (excluding, in the case of the named individuals, traffic violations and misdemeanors), or was a party to any judicial or administrative proceeding (except for matters that were dismissed without sanction or settlement) that resulted in a judgment, decree or final order enjoining such persons from future violations of, or prohibiting activities subject to, federal or state laws, or a finding of a violation of federal or state securities laws.
3
Item 4. Terms of the Transaction
Regulation M-A Item 1004
(a)
Material terms
.
(1) Not applicable.
(2)(i) The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Summary Term Sheet
Questions and Answers about the Special Meeting and the Merger
(2)(ii) The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Summary Term Sheet
Questions and Answers about the Special Meeting and the Merger
Special FactorsCertain Effects of the Merger
The Merger AgreementEffect of the Merger on the Common Stock
The Merger AgreementTreatment of Stock Options and Other Stock Based Awards
The Merger AgreementPayment for the Common Stock in the Merger
(2)(iii) The information set forth in the Proxy Statement under the following captions is incorporated herein by reference
Special FactorsBackground of the Merger
Special FactorsReasons for the Merger; Recommendation of the Special Committee and of the Board of Directors; Fairness of the Merger
Special FactorsMr. Marquezs Purpose and Reasons for the Merger
Special FactorsPurposes and Reasons for, and Plans for the Company after, the Merger
(2)(iv) The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Questions and Answers about the Special Meeting and the Merger
The Special MeetingRequired Vote
The Merger AgreementConditions to the Merger
(2)(v) The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Summary Term Sheet
4
Special FactorsCertain Effects of the Merger
Special FactorsInterests of Venocos Directors and Executive Officers in the Merger
(2)(vi) The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:
Special FactorsAnticipated Accounting Treatment of the Merger
(2)(vii) The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:
Special FactorsMaterial United States Federal Income Tax Considerations
(c)
Different terms
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Special FactorsCertain Effects of the Merger
Special FactorsInterests of Venocos Directors and Executive Officers in the Merger
The Merger AgreementEffect of the Merger on the Common Stock
(d)
Appraisal rights
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Rights of Appraisal
Annex CSection 262 of the Delaware General Corporation Law
(e)
Provisions for unaffiliated security holders
. The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:
Provisions for Unaffiliated Stockholders
(f)
Eligibility for listing or trading
. Not applicable.
Item 5. Past Contacts, Transactions, Negotiations and Agreements
Regulation M-A Item 1005
(a)(1) - (2)
Transactions
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Special FactorsBackground of the Merger
Special FactorsInterests of Venocos Directors and Executive Officers in the Merger
Agreements Involving Common Stock; Transactions between Marquez Investors and the Company
(b) - (c)
Significant corporate events; Negotiations or contacts
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Special FactorsBackground of the Merger
5
Special FactorsReasons for the Merger; Recommendation of the Special Committee and of the Board of Directors; Fairness of the Merger
Special FactorsMr. Marquezs Purpose and Reasons for the Merger
Special FactorsMr. Marquezs Position as to Fairness of the Merger
Special FactorsParents, Merger Subs, the Marquez Affiliated Entities and Bernadette Marquezs Position as to Fairness of the Merger
Special FactorsPurposes and Reasons for, and Plans for the Company after, the Merger
Special FactorsInterests of Venocos Directors and Executive Officers in the Merger
The Merger Agreement
Agreements Involving Common Stock; Transactions between Marquez Investors and the Company
(e)
Agreements involving the subject companys securities
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Special FactorsCertain Effects of the Merger
Special FactorsInterests of Venocos Directors and Executive Officers in the Merger
The Special MeetingRequired Vote
The Merger Agreement
Agreements Involving Common Stock; Transactions between Marquez Investors and the Company
Item 6. Purposes of the Transaction and Plans or Proposals.
Regulation M-A Item 1006
(b)
Use of securities acquired
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Special FactorsCertain Effects of the Merger
The Merger AgreementEffect of the Merger on the Common Stock
The Merger AgreementTreatment of Stock Options and Other Stock Based Awards
(c)(1)-(8)
Plan
s. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Questions and Answers about the Special Meeting and the Merger
Special FactorsBackground of the Merger
Special FactorsReasons for the Merger; Recommendation of the Special Committee and of the Board of Directors; Fairness of the Merger
Special FactorsMr. Marquezs Purpose and Reasons for the Merger
6
Special FactorsPurposes and Reasons for, and Plans for the Company after, the Merger
Special FactorsCertain Effects of the Merger
Special FactorsFinancing
Special FactorsInterests of Venocos Directors and Executive Officers in the Merger
The Merger AgreementStructure of the Merger
The Merger AgreementEffect of the Merger on the Common Stock
The Merger AgreementTreatment of Stock Options and Other Stock Based Awards
Item 7. Purposes, Alternatives, Reasons and Effects
Regulation M-A Item 1013
(a)
Purposes
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference
Special FactorsBackground of the Merger
Special FactorsReasons for the Merger; Recommendation of the Special Committee and of the Board of Directors; Fairness of the Merger
Special FactorsMr. Marquezs Purpose and Reasons for the Merger
Special FactorsPurposes and Reasons for, and Plans for the Company after, the Merger
(b)
Alternatives
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Special FactorsBackground of the Merger
Special FactorsReasons for the Merger; Recommendation of the Special Committee and of the Board of Directors; Fairness of the Merger
Special FactorsPurposes and Reasons for, and Plans for the Company after, the Merger
(c)
Reasons
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Special FactorsBackground of the Merger
Special FactorsReasons for the Merger; Recommendation of the Special Committee and of the Board of Directors; Fairness of the Merger
Special FactorsMr. Marquezs Purpose and Reasons for the Merger
Special FactorsMr. Marquezs Position as to Fairness of the Merger
Special FactorsParents, Merger Subs, the Marquez Affiliated Entities and Bernadette Marquezs Position as to Fairness of the Merger
7
Special FactorsPurposes and Reasons for, and Plans for the Company after, the Merger
Special FactorsCertain Effects of the Merger
(d)
Effects.
The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Questions and Answers about the Special Meeting and the Merger
Special FactorsBackground of the Merger
Special FactorsReasons for the Merger; Recommendation of the Special Committee and of the Board of Directors; Fairness of the Merger
Special FactorsMr. Marquezs Purpose and Reasons for the Merger
Special FactorsPurposes and Reasons for, and Plans for the Company after, the Merger
Special FactorsCertain Effects of the Merger
Special FactorsInterests of Venocos Directors and Executive Officers in the Merger
Special FactorsMaterial United States Federal Income Tax Considerations
The Merger AgreementStructure of the Merger
Item 8. Fairness of the Transaction
Regulation M-A Item 1014
(a) - (b)
Fairness; Factors considered in determining fairness
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Special FactorsBackground of the Merger
Special FactorsReasons for the Merger; Recommendation of the Special Committee and of the Board of Directors; Fairness of the Merger
Special FactorsOpinion of Merrill Lynch, Pierce, Fenner & Smith Incorporated
Special FactorsMr. Marquezs Purpose and Reasons for the Merger
Special FactorsMr. Marquezs Position as to Fairness of the Merger
Special FactorsParents, Merger Subs, the Marquez Affiliated Entities and Bernadette Marquezs Position as to Fairness of the Merger
Special FactorsPurposes and Reasons for, and Plans for the Company after, the Merger
Special FactorsInterests of Venocos Directors and Executive Officers in the Merger
Annex BOpinion of Merrill Lynch, Pierce, Fenner & Smith Incorporated
(c)
Approval of security holders
. The information set forth in the Proxy Statement under the following captions
8
is incorporated herein by reference:
Summary Term SheetRequired Vote
Summary Term SheetConditions to the Merger
Questions and Answers about the Special Meeting and the Merger
The Special MeetingRecord Date and Quorum
The Special MeetingRequired Vote
The Merger AgreementConditions to the Merger
(d)
Unaffiliated representative
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Special FactorsBackground of the Merger
Special FactorsReasons for the Merger; Recommendation of the Special Committee and of the Board of Directors; Fairness of the Merger
(e)
Approval of directors
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Special FactorsBackground of the Merger
Special FactorsReasons for the Merger; Recommendation of the Special Committee and of the Board of Directors; Fairness of the Merger
(f)
Other offers
. Not applicable.
Item 9. Reports, Opinions, Appraisals and Certain Negotiations
Regulation M-A Item 1015
(a) - (c)
Report, opinion or appraisal; Preparer and summary of the report, opinion or appraisal; Availability of documents
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Special FactorsBackground of the Merger
Special FactorsReasons for the Merger; Recommendation of the Special Committee and of the Board of Directors; Fairness of the Merger
Special FactorsOpinion of Merrill Lynch, Pierce, Fenner & Smith Incorporated
Where You Can Find Additional Information
Annex BOpinion of Merrill Lynch, Pierce, Fenner & Smith Incorporated
The
presentation,
dated
January
16,
2012,
of
Merrill
Lynch,
Pierce,
Fenner
&
Smith
Incorporated,
preliminary
discussion
materials,
dated
December
11,
2011
and
October
7,
2011,
Venoco special committee update, dated September 8, 2011, and comparison of business plan projections, dated September 15, 2011, September 29, 2011 and October 25, 2011,
of
Merrill
Lynch,
Pierce,
Fenner
&
Smith
Incorporated
and
Strategic
Energy
Advisors,
to
the
Special
Committee
of
the
Board
of
Directors
of
the
Company
are
filed
as
Exhibits
(c)(2),
(c)(3),
(c)(4), (c)(7), (c)(8), (c)(9) and (c)(10),
respectively,
and
are
incorporated
by
reference
herein. The discussion materials,
dated
November
30,
2011
and
December
15,
2011,
of
Citibank
for
Timothy
M.
Marquez
are
filed
as
Exhibits
(c)(5)
and
(c)(6), respectively, and are incorporated by reference herein.
The reports, opinions or appraisals referenced in this Item 9 will be made available for inspection and copying at the principal executive offices of the Company during its regular business hours.
9
Item 10. Source and Amounts of Funds or Other Consideration
Regulation M-A Item 1007
(a) - (b), (d)
Source of funds; Conditions; Borrowed funds
. The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:
Special FactorsFinancing
(c)
Expenses.
The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Special FactorsFees and Expenses
The Merger AgreementFees and Expenses
Item 11. Interest in Securities of the Subject Company
Regulation M-A Item 1008
(a)
Securities ownership
. The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:
Important Information Concerning VenocoSecurity Ownership of Certain Beneficial Owners and Management
(b)
Securities transactions
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Agreements Involving Common Stock; Transactions between Marquez Investors and the CompanyAgreements Involving Common Stock
Important Information Concerning VenocoTransactions in Common Stock
In the ordinary course of business, employees of the Company are permitted to purchase shares of common stock pursuant to the Companys Employee Stock Purchase Plan. In addition, from time to time in the ordinary course of business, the Company has issued awards of restricted shares of the Companys Common Stock pursuant to the terms of its existing employee compensation plans.
Item 12. The Solicitation or Recommendation
Regulation M-A Item 1012
(d)
Intent to tender or vote in a going-private transaction
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Questions and Answers about the Special Meeting and the Merger
Special FactorsReasons for the Merger; Recommendation of the Special Committee and of the Board of Directors; Fairness of the Merger
Special FactorsMr. Marquezs Purpose and Reasons for the Merger
10
Special FactorsPurposes and Reasons for, and Plans for the Company after, the Merger
The Special MeetingRequired Vote
Agreements Involving Common Stock; Transactions between Marquez Investors and the CompanyAgreements Involving Common Stock
(e)
Recommendation of others
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Special FactorsReasons for the Merger; Recommendation of the Special Committee and of the Board of Directors; Fairness of the Merger
Special FactorsMr. Marquezs Purpose and Reasons for the Merger
Special FactorsMr. Marquezs Position as to Fairness of the Merger
Special FactorsPurposes and Reasons for, and Plans for the Company after, the Merger
Item 13. Financial Information
Regulation M-A Item 1010
(a)
Financial statements
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Important Information Concerning VenocoHistorical Selected Financial Information
Important Information Concerning VenocoRatio of Earnings to Fixed Charges
Important Information Concerning VenocoBook Value Per Share
Where You Can Find Additional Information
The audited financial statements set forth in the Companys Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2011 are incorporated herein by reference.
(b)
Pro forma information
. Not applicable.
Item 14. Persons/Assets, Retained, Employed, Compensated or Used
Regulation M-A Item 1009
(a)-(b)
Solicitations or recommendations; Employees and corporate assets
. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
Questions and Answers about the Special Meeting and the Merger
Special FactorsBackground of the Merger
Special FactorsFees and Expenses
The Special MeetingSolicitation of Proxies
11
Item 15. Additional Information
Regulation M-A Item 1011
(b) Not applicable.
(c)
Other material information
. The information set forth in the Proxy Statement, including all annexes thereto, is incorporated herein by reference.
Item 16. Exhibits
Regulation M-A Item 1016
(a)(1) Proxy Statement of Venoco, Inc. (incorporated by reference to the Schedule 14A filed concurrently with the Securities and Exchange Commission).
(a)(2) Form of Proxy Card (incorporated herein by reference to the Proxy Statement).
(a)(3) Letter to Venoco Stockholders (incorporated herein by reference to the Proxy Statement).
(a)(4) Notice of Special Meeting of Stockholders (incorporated herein by reference to the Proxy Statement).
(a)(5) Press Release dated January 16, 2012 (filed as Exhibit 99.1 to the Companys Current Report on Form 8-K, filed January 17, 2012 and incorporated herein by reference).
(b) None.
(c)(1) Opinion of Merrill Lynch, Pierce, Fenner & Smith Incorporated, dated January 16, 2012 (incorporated herein by reference to Annex B of the Proxy Statement).
(c)(2) Presentation, dated January 16, 2012, of Merrill Lynch, Pierce, Fenner & Smith Incorporated for the Special Committee of the Board of Directors of Venoco, Inc.*
(c)(3) Preliminary Discussion Materials, dated December 11, 2011, of Merrill Lynch, Pierce, Fenner & Smith Incorporated and Strategic Energy Advisors for the Special Committee of the Board of Directors of Venoco, Inc.*
(c)(4) Preliminary Discussion Materials, dated October 7, 2011, of Merrill Lynch, Pierce, Fenner & Smith Incorporated and Strategic Energy Advisors for the Special Committee of the Board of Directors of Venoco, Inc.*
(c)(5) Discussion Materials, dated November 30, 2011, of Citibank for Timothy M. Marquez.**
(c)(6) Discussion Materials, dated December 15, 2011, of Citibank for Timothy M. Marquez.***
(c)(7) Venoco Special Committee Update, dated September 8, 2011, of Merrill Lynch, Pierce, Fenner & Smith Incorporated and Strategic Energy Advisors for the Special Committee of the Board of Directors of Venoco, Inc.
****
(c)(8) Materials, dated September 15, 2011, of Merrill Lynch, Pierce, Fenner & Smith Incorporated and Strategic Energy Advisors for the Special Committee of the Board of Directors of Venoco, Inc. regarding comparison of business plan projections.
****
(c)(9) Materials, dated September 29, 2011, of Merrill Lynch, Pierce, Fenner & Smith Incorporated and Strategic Energy Advisors for the Special Committee of the Board of Directors of Venoco, Inc. regarding comparison of business plan projections.
****
(c)(10) Materials, dated October 25, 2011, of Merrill Lynch, Pierce, Fenner & Smith Incorporated and Strategic Energy Advisors for the Special Committee of the Board of Directors of Venoco, Inc. regarding comparison of business plan projections.
****
(d)(1) Agreement and Plan of Merger, dated January 16, 2012, by and among Venoco, Inc., Denver Parent Corporation, Denver Merger Sub Corporation, and, solely with respect to the sections specified therein, Timothy M. Marquez (incorporated herein by reference to Annex A of the Proxy Statement).
(d)(2) Voting Agreement, dated January 16, 2012, by and among Venoco, Inc., the Marquez Trust and the Timothy and Bernadette Marquez Foundation (incorporated herein by reference to Annex D of the Proxy Statement).
12
(d)(3) Rollover Commitment Letter, dated January 16, 2012, by and among the Marquez Trust, the Timothy and Bernadette Marquez Foundation and Denver Parent Company (incorporated herein by reference to Annex E of the Proxy Statement).
(d)(4) Registration Rights Agreement, dated as of August 25, 2006, by and between Venoco, Inc. and the Marquez Trust (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of Venoco, Inc. filed on August 31, 2006).
(d)(5) Amendment to Registration Rights Agreement and Joinder, dated as of May 23, 2007, by and among Venoco, Inc., the Marquez Trust and the Marquez Foundation (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of Venoco, Inc. filed on May 25, 2007).
(f)(1) Section 262 of the Delaware General Corporation Law (incorporated herein by reference to Annex C of the Proxy Statement).
(g) None.
* Previously filed on February 13, 2012.
** Previously filed on March 21, 2012.
*** Previously filed on April 9, 2012.
**** Previously filed on April 24, 2012.
13
SIGNATURE
After due inquiry and to the best of each of the undersigneds knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.
Dated as of May 3, 2012
|
VENOCO, INC.
|
|
|
|
|
|
By:
|
/s/ Timothy M. Marquez
|
|
|
Name: Timothy M. Marquez
|
|
|
Title: Chief Executive Officer
|
|
|
|
|
|
DENVER PARENT CORPORATION
|
|
|
|
|
|
By:
|
/s/ Timothy M. Marquez
|
|
|
Name: Timothy M. Marquez
|
|
|
Title: Chief Executive Officer
|
|
|
|
|
|
DENVER MERGER SUB CORPORATION
|
|
|
|
|
|
By:
|
/s/ Timothy M. Marquez
|
|
|
Name: Timothy M. Marquez
|
|
|
Title: Chief Executive Officer
|
|
|
|
|
|
/s/ Timothy M. Marquez
|
|
TIMOTHY M. MARQUEZ
|
|
|
|
/s/ Bernadette Marquez
|
|
BERNADETTE MARQUEZ
|
|
|
|
|
|
MARQUEZ TRUST
|
|
|
|
|
By:
|
/s/ Timothy M. Marquez
|
|
|
Name: Timothy M. Marquez
|
|
|
Title: Trustee
|
|
|
|
|
By:
|
/s/ Bernadette Marquez
|
|
|
Name: Bernadette Marquez
|
|
|
Title: Trustee
|
|
|
|
|
|
|
|
TIMOTHY AND BERNADETTE MARQUEZ FOUNDATION
|
|
|
|
|
By:
|
/s/ Timothy M. Marquez
|
|
|
Name: Timothy M. Marquez
|
|
|
Title: Trustee
|
|
|
|
|
By:
|
/s/ Bernadette Marquez
|
|
|
Name: Bernadette Marquez
|
|
|
Title: Trustee
|
|
|
|
|
By:
|
/s/ David Mokros
|
|
|
Name: David Mokros
|
|
|
Title: Trustee
|
14
Venoco, Inc. (NYSE:VQ)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Venoco, Inc. (NYSE:VQ)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024